Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells. - Golumba‐Nagy, Viktoria; Yan, Shuaifeng; Steinbach‐Knödgen, Eva; Thiele, Jan; Esser, Ruth L.; Haak, Thomas H.; Nikiforov, Anastasia; Meyer, Anja; Seeger‐Nukpezah, Tamina; Kofler, David M. (Physiological Reports, 2023)